Mark B. Parshall

TL;DR: There is a critical need for interdisciplinary translational research to connect Dyspnea mechanisms with clinical treatment and to validate dyspnea measures as patient-reported outcomes for clinical trials.

TL;DR: Analytical challenges inherent in the interpretation of focus group data are described and approaches for enhancing the rigor of analysis and the reliability and validity of focus groups findings are suggested.

TL;DR: The ED plays a unique role in the continuum of AHFS treatment, functioning for most patients as the initial point of definitive healthcare contact, the location where primary stabilization is achieved, and the site where disposition decisions are generally made.

TL;DR: The Multidimensional Dyspnea Profile provides a unified, reliable instrument for both clinical and laboratory research and review published evidence regarding its measurement properties.

TL;DR: Dyspnea duration does not appear to be a valid criterion for judging condition severity in HF-related visits to the ED, and subjects reported high levels of distress and intensity at Decision, regardless of dyspneaduration.